The conformation and dynamics of a protein are essential in characterizing the protein folding/unfolding intermediate state. They are closely involved in the packing and site-specific interactions of peptide elements to build and stabilize the tertiary structure of the protein. In this study, it was confirmed that trypsin inhibitor obtained from seeds of bitter gourd (BGTI) adopted a peculiar but plausible conformation and dynamics in the unfolding intermediate state. The fluorescence spectrum of one of two tryptophan residues of BGTI, Trp9, shifted to the blue side in the presence of 2-3 M guanidine hydrochloride, although the other, Trp54, did not show this spectral shift. At the same time, the motional freedom of Trp9 revealed by a timeresolved fluorescence study decreased, suggesting that the segmental motion of this residue was more restricted. These results indicate that BGTI takes such a conformation state that the hydrophobic core and loop domains arranging Trp9 and Trp54 respectively are heterogeneously packed in the unfolding intermediate state.
The unique three-dimensional structure of a protein is maintained by weak attractive interactions between the peptide elements completing biological roles. When the attractive interactions are weakened under mild denaturation conditions, the partially structured or unfolded state is frequently recognized. Such a conformational state is known as the molten globule (MG) state of the protein. The MG state is considered to be the general folding/unfolding intermediate state of the protein, and this has been noted as a milestone in elucidating the protein folding mechanism. [1] [2] [3] The fundamental properties of the MG state have been described by various physical and analytical methods. The CD spectra in the far-and near-UV regions demonstrate that the propensity of the secondary structures is retained although the order of the unique tertiary structures is reduced or loosened. [4] [5] [6] The ANS binding studies suggest that the hydrophobic parts are exposed to the protein surface due to the enhanced fluctuation of the amino acid side chain. 7) Middle and small-angle X-ray scattering studies have shown that the ordering in the internal structure was reduced and that the molecular shape and size were altered. [8] [9] [10] Such experimental results constitute the conceptional criteria for the MG and MG-like state as the folding/unfolding intermediate state, and characterize their structure and conformation. However, more detailed information on the packing and site-specific interactions of peptide elements is required to determine the protein folding/unfolding mechanism under the potent framework, landscape or nucleation-condensation model. 11, 12) The MG state of a protein is inherently disordered. Therefore, investigators rely on some spectroscopic methods to investigate the conformation and dynamics of the MG state. It is difficult to determine a disordered structure by crystallographic analysis. While NMR, Raman, and CD spectroscopic methods have been generally applied, making the best use of their advantages, fluorescence spectroscopy is one of the most powerful methods of studying the disordered state of a protein. The fluorescence spectral sensitivity and timeresolution power are so high that subtle conformation changes and their dynamics can be screened out through the fluorescence spectroscopic properties of tryptophan and other intrinsic fluorophores in the protein. In the case of a protein in which the location of the tryptophan residue is specified in native structure, the fluorescence study provides delicate and quantitative information on the protein conformation in disordered cases.
In the present study, the feature of conformation and dynamics in the unfolding intermediate state of bitter gourd trypsin inhibitor (BGTI) was investigated by steady-state and time-resolved fluorescence methods. Many trypsin inhibitors have provided valuable information on the protein folding/unfolding process and mechanism of the model protein. BGTI is an also interesting subject, since its simple crystallographic structure is very similar to chymotrypsin inhibitor 2, which has a specific nucleation site for folding around the N-terminal -helix domain. 13) Furthermore, the native structure of BGTI can be determined by X-ray crystallographic analysis with almost 1 Å resolution, and it has been confirmed that BGTI consists of a densely packed domain including two -helices and a sparse loop domain. Two tryptophan residues, Trp9 and Trp54, are arranged in a densely packed domain and the loop domain respectively (Fig. 1) . In order to determine local alterations of the conformation and dynamics in the folding/unfolding of BGTI through fluorescence spectroscopy, two mutants, W54F and W9F, in which Trp54 and Trp9 were replaced with phenylalanine, were prepared. These single Trp-containing mutants of BGTI revealed topological characteristics in the unfolding intermediate state of BGTI.
Materials and Methods
Materials. Restriction enzymes and DNA modifying enzymes were purchased from MBI Fermentas (Hanover, MD) and Toyobo (Osaka, Japan) respectively. Thermo sequenase cycle sequencing kits containing 7-deaza-dGTP were from GE Healthcare UK (Buckinghamshire, UK). A chameleon double standard sitedirected mutagenesis kit was from Strategene (La Jolla, CA). Expression plasmid, pET-16b, was from Novagen (Madison, WI). Escherichia coli strains JM109 and Xl1-blue were used as host cells in cloning and mutagenesis, and strain BL21 (DE3) was used for host cells in producing recombinant BGTI and its mutant proteins. All other common chemicals and reagents were purchased at the highest purity available and were used without further purification.
Mutagenesis and DNA sequencing. In mutagenesis experiments, the cDNA coding for BGTI in plasmid pET-16b, which was kindly offered by Dr. M. Kimura of Kyushu University, was used. Site-directed mutagenesis was performed by the unique site elimination method developed by Deng and Nickoloff. 14) All the mutations introduced were confirmed by DNA sequencing with a DNA sequencer (DSQ-1000, Shimadzu, Kyoto, Japan) using a thermo sequenase cycle sequencing kit (GE Healthcare UK).
Expression and purification of the recombinant proteins. The genes encoding wild-type (WT) and mutant BGTI were expressed in E. coli strain BL21 (DE3) using expression plasmid pET-16b. WT and mutant BGTI were purified from extracts of the cells by a combination of HiTrap Chelating column and ion exchange column chromatographies on the Biologic DuoFlow chromatography system (BioRad, Hercules, CA). First, wild-type and mutant BGTIs were separated from other proteins with a His tag trap column, which was prepared by conjugating a HiTrap Chelating column with Ni 2þ . After desalting and condensation, the His tag was removed by incubating BGTI with Factor Xa for 12 h. In order to remove the His tag and undigested BGTI, the sample solution was applied to the His tag trap column again. The eluted sample was purified by cation exchange chromatography using a HiPrep 16/10 CM FF column, after desalting. The purities of the wildtype and mutant BGTI were confirmed with a HPLC on a Superdex Peptide 10/300 GL column and SDS-PAGE using 15% polyacrylamide gel. The concentrations of BGTI and its mutants were determined by the spectrophotometric method. About 5 mg of wild-type and mutant BGTIs was obtained from 1 liter of LB medium.
The purified BGTI and its mutants, W54F-BGTI and W9F-BGTI, were prepared in 20 mM Tris-HCl buffer, pH 7.8, for unfolding experiments. Small aliquots of the sample solution were added to the reaction mixtures containing the desired concentrations of Gdn. These protein solutions were incubated at 25 C for 5 h to attain unfolding equilibrium under conditions including various concentrations of Gdn. Under these conditions, no further changes in any experimental parameters used here, such as fluorescence spectra and decay kinetics, were recognized after incubation.
Steady-state and time-resolved fluorescence measurements. Steady-state fluorescence measurements were performed on a Hitachi 850 fluorescence spectrophotometer (Hitachi, Tokyo). The excitation and emission spectra were strictly corrected by the excitation and detection system. The effects of undesired stray light were removed by subtracting the emission contribution from the buffer solution.
The fluorescence quenching experiments were performed based on the usual Stern-Volmer equation:
where F 0 and F are fluorescence intensities in the absence and the presence of fluorescence quencher, [Q], respectively, and K SV is the Stern-Volmer constant. The fluorescence intensities, F 0 and F, were obtained by measuring the fluorescence spectra of BGTI equilibrated with a buffer solution including the various concentrations of Gdn titrating with the fluorescence quencher, acrylamide. Steady-state fluorescence anisotropy was measured using the same instrument. After measuring the parallel (I vv ) and perpendicular (I vh ) components against the vertical excitation, the fluorescence anisotropy (r) was calculated using the definition
where G is the grating factor, decided by the intensity ratio of the vertical component to the horizontal one against the horizontal excitation. Time-resolved fluorescence and fluorescence anisotropy were measured by a combination of sub-picosecond laser with the time-correlated single photon counting method (TCSPC). The excitation pulse (295 nm) was separated from a combination of subpicosecond Ti:sapphire laser (Tsunami, Spectra-Physics, Stratford, CT), pulse picker with a second harmonic generator (model 3980, Spectra-Physics) and a third harmonic generator (GWU, Spectra-Physics). The repetition rate was 800 kHz, and the excitation pulse width obtained was FWHM ¼ 100 fs. The fluorescence emission pulse was detected with a multi-channel plate type photomultiplier (3809U-50, Hamamatsu Photonics, Shizuoka, Japan). The output signals of the time-toamplitude converter (TAC, 457, Ortec, Oak Ridge, TN) were accumulated in 2,048 channels in a multi-channel analyzer (Maestro-32, Ortec). The channel width was 11 ps/ch. The details of the apparatus and procedures are described in our previous report. 15) The fluorescence decay kinetics of BGTI were described with a linear combination of exponentials:
where i is the fluorescence decay time of the i-th component and i is the corresponding pre-exponential factor. i and i were determined by iterative convolution and non-linear curve fitting methods. The adequacy of curve-fitting was judged by the residual plots, the serial variance ratio (SVR), and the sigma value (). 16) Measurements of fluorescence anisotropy decays were performed with the same TCSPC system, but a Gran-Taylor polarizer was set just behind the sample to measure the decays of vertical (I vv ðtÞ) and horizontal (I vh ðtÞ) components against vertical excitation. I vv ðtÞ and I vh ðtÞ were related to the fluorescence decay (FðtÞ) and anisotropy decay (rðtÞ) by the following Eqs. 4 and 5:
The fluorescence anisotropy decay kinetics was given by Eq. 6:
where i and i were the i-th rotational correlation time and the corresponding amplitude respectively. Fluorescence anisotropy decay was determined by simultaneous global analysis of I vv and I vh using Eqs. 3-6. Their adequacies were confirmed by SVR and for I vv and I vh . All fluorescence measurements were performed at 25 C.
CD spectrum measurement. The CD spectra of BGTI and its mutants were recorded on a J-720 spectropolarimeter (JASCO, Tokyo). The sample solution of BGTI was buffered with 20 mM Tris-HCl buffer, pH 7.8. The protein concentrations used for CD spectrum were adjusted to 0.1 mg/ml. A CD cuvette with 1 mm of optical-path length was used for measurements in the far-UV region.
Results and Discussion
The fluorescence spectra of W9F-and W54F-BGTI equilibrated with 0, 3, and 6 M of Gdn are shown in Fig. 2 . The fluorescence spectra of WT-and W9F-BGTI were very similar (data not shown). Their fluorescence maxima were seen at 342 nm at 0 and 3 M of Gdn, but shifted to 352 nm at 6 M. The spectral distribution of W54F, in which The Trp residue is located at the more densely packed site, was quite different from the others. The fluorescence maximum wavelength was observed at 335 nm in the absence of Gdn, but it shifted to 330 nm in the solution including 3 M of Gdn. Equilibrated with 6 M Gdn, the fluorescence maximum of W54F was also observed at 355 nm, similarly to that of W9F.
The steady-state fluorescence spectroscopic properties of W9F and W54F, maximum wavelength, intensity, and anisotropy, are simultaneously plotted against the concentration of Gdn in Fig. 3 . In these equilibratory unfolding profiles, the differences in the behaviors of the fluorescence maximum wavelength and anisotropy between W9F and W54F should be noted. The fluorescence spectrum of Trp9 in W54F shifted to the blue side, giving a maximum intensity at 330 nm at around 3 M of Gdn. In the Gdn concentration region higher than 3 M, the fluorescence spectrum showed a red shift. On the other hand, Trp54 in W9F exclusively shifted to 355 nm at 6 M Gdn. The steady-state fluorescence anisotropy of W9F-BGTI was 0.073 in the native state, and it started to decrease gradually at 2 M of Gdn, giving 0.063 at 6 M. Because of the probable limitation of the segmental motion of Trp9, the fluorescence anisotropy of W54F-BGTI was 2 times higher than that of W9F in the native state. The fluorescence anisotropy of W54F showed larger values at around 3 M of Gdn concomitantly with the transient blue shift of the fluorescence spectrum. The fluorescence intensities of W9F-BGTI exclusively decreased, although they increased once at concentrations lower than 1 M of Gdn. The fluorescence intensity of Trp9 in W54F-BGTI increased gradually with increasing Gdn concentrations, reaching constant intensity in the region of 2-4 M of Gdn, and then steeply increased at 5 and 6 M. The equilibratory unfolding profile of WT-BGTI was very similar to one of W9F, suggesting that Trp54 contributes much more to the total fluorescence of WT than Trp9. The result of WT-BGTI is not shown. These results consistently suggest that the two domains of BGTI where Trp9 and Trp54 locate sustain quite different conformations, and that the hydrophobic domain gives Trp9 more hydrophobic circumstance and is more compactly packed around 2-4 M of Gdn.
The CD spectra of W9F-and W54F-BGTI in the far-UV region were almost the same, although some effect of the replacement of Phe9 with Trp in -helix was seen (Fig. 4, insertion) . They showed a single large minimum at 205 nm, attributable to 0 -À transition of the -helix. Although it is difficult to analyze the Gdn concentration dependence of the CD spectrum in the full-spectral region, since the presence of high concentrations of Gdn distorts the spectrum, fortunately, the propensity of the secondary structure could be estimated by the ellipticity at 210 nm. Their plots against Gdn concentration showed that the secondary structures of mutant BGTIs slightly increased in the presence of 3 M Gdn, although it steeply decreased at higher than 4 M.
Fig. 3. Equilibratory Unfolding Profiles of W9F-BGTI (a) and W54F-BGTI (b).
Fluorescence intensity, maximum wavelength, and anisotropy are shown by curves 1, 2 and 3 respectively. Fluorescence intensity and anisotropy were measured at the maximum wavelengths. The fluorescence solute quenching method has been used frequently to detect a conformational change in which the internal tryptophan residue is exposed to the protein surface. Every plot of F 0 =F for mutant BGTIs against the acrylamide concentration showed a straight line estimating the Stern-Volmer constant, K SV (data not shown). The obtained results are summarized in Table 1 . For the calculation of the quenching constant, k q , K SV and the fluorescence lifetime given in Table 2 were used. The quenching and Stern-Volmer constants for W9F-BGTI became larger and, on the other hand, W54F-BGTI gave the smallest value in the presence of 3 M Gdn. The fluorescence quenching constant is proportional to the cross section for the collision of the quencher molecule with the tryptophan residue in the excited state. Therefore, it is more meaningful than K SV to investigate the packing state around the tryptophan residue. According to the results shown in Table 1 , the accessibility of the quencher molecule to Trp9 was much higher than that to Trp54, although Trp9 gave a smaller K SV than Trp54. Probably, this discrepancy between K SV and k q is due to the extraordinarily shorter fluorescence lifetime of Trp9. In spite of this, the Gdn concentration dependences of K SV for the fluorescence quenching of mutant BGTIs also confirm that the peptide element, including Trp9 and Trp54, is heterogeneously packed, the former compactly, the latter loosely in the intermediate state.
While WT-BGTI showed triple fluorescence decay kinetics, W9F-and W54F-BGTI gave the best fit to double and to triple exponential kinetics according to the concentrations of denaturant ( Table 2 ). The fluorescence decay of Trp9 of W54F-BGTI was very fast. The longer and shorter decay times were in the range of 160-340 ps and 40-140 ps respectively at 0-3 M of Gdn. On the other hand, the fluorescence lifetime of Trp54 of W9F-BGTI was observed to be longer, suggesting that this residue locates at the less interacting site in the polypeptide cage. The faster decay times of both the two Trps were prolonged more than 3 times, and the average lifetime ( av ), defined as av ¼ AE i i , of W9F was shortened, but one of W54F was prolonged in the intermediate state. Such differences in decay parameters indicate that the circumstances surrounding Trp9 and Trp54 are delicately modified in the intermediate state.
The changes in the fluorescence decay kinetics of W9F-and W54F-BGTI from double to triple exponentials correspond to the large-scaled conformational conversion to the unfolded state of these mutant BGTIs at 6 M of Gdn. WT-BGTI includes Trp9 and Trp54; neverthless, its fluorescence showed triple exponential decay kinetics in the absence of Gdn. Unfortunately, our detection system could not resolve quadruple fluorescence decay components coming from the two tryptophan residues, the decay kinetics of which can be described by double exponentials.
Time-resolved fluorescence depolarization studies give interesting insights into the characteristics of the intermediate state from the viewpoint of conformational dynamics, because the fluorescence anisotropy decay is dependent on rotational correlation time and the motional freedom of the peptide elements, including the tryptophan residue. The fluorescence anisotropy decay profiles of W9F-and W54F-BGTI are shown in Fig. 5 together with the decay of the parallel and perpendicular fluorescence components, by which the anisotropy decay parameters were determined using Eqs. 3-6. Although the decay parameters changed according to the Gdn concentrations, the fluorescence anisotropy decay kinetics were described with double exponentials under every condition investigated here. The rotational correlation times obtained and corresponding amplitudes are summarized in Table 3 . The longer correlation times, probably corresponding to the entire rotation of BGTIs, were in the range of 2 to 7.5 ns at Gdn concentrations of 0-2 M, but changed remarkably in 6 M Gdn. Trp9 in W54F-BGTI showed very short rotational correlation times (20-50 ps) at Gdn concentrations from 0 to 3 M, while they were prolonged at 6 M. On the other hand, the shorter correlation times of Trp54 were comparatively longer within a range of 0.3 to 0.6 ns. Since the rotational correlation time given by the fluorescence depolarization method is decided by the product of the size of the rotator and interaction with the surroundings, definitive discussion of the segmental motions of Trp residue must be limited. However, the motional freedom, given by the fractional amplitude, f ¼ 1 =ð 1 þ 2 Þ, is an excellent criterion of the conformational dynamics of tryptophan residue in the polypeptide cage of the protein. The motional freedoms of the segmental motion of Trp9 and Trp54 are plotted against the various concentrations of Gdn (Fig. 6) . While the Fluorescence anisotropy decay was calculated using the parameters giving the best fit to the vertically (I vv ) and horizontally (I vh ) polarized fluorescence decay curves. The excitation wavelength was 295 nm. VV, VH, and r in each panel are I vv , I vh , and the fluorescence anisotropy decay profile respectively. Emission was monitored at the fluorescence maximum wavelength. The channel width was 11 ps/ch. [17] [18] [19] Even in small-sizes proteins such as -lactalbumin and canine lysozyme, the ideal properties of the MG state are exhibited in the presence of low concentrations of denaturants and under the extremely acidic conditions. 5) The consensus as to the characteristic features of the MG state formed through the above proteins is that the secondary structure of the MG state is strictly preserved, but its tertiary structure is reduced or loosened. 4, 6) Because the secondary structure holds but the originally loosely packed domain in the native state is already loosened in the presence of 3-4 M Gdn, the intermediate state of BGTI formed at 3-4 M of Gdn presumably corresponds to the MG state. However, the results obtained from the fluorescence spectrum, depolarization, and quenching analysis indicated that the hydrophobic core domain of BGTI took a more compact form at the intermediate state than in the native state. Because the fluorescence maximum wavelength of Trp9 shifted to 330 nm, the access of the fluorescence quencher molecule to Trp9 was suppressed and the motional freedom of Trp9 was reduced 50% in the intermediate state. Kuznetsova et al. reported that muscle creatine kinase folded and unfolded through a specific conformation state between the native and MG state and that tryptophan residue was immobilized in that state. 20) The behavior of Trp9 in W54F-BGTI had some similarity with creatine kinase. But in the unfolding process of BGTI, the packing around Trp9 The segmental motion of tryptophan residue is described with cone angles (), which are calculated based on the experimental data on motional freedom using the relations between and f : [21] [22] [23] ð1 À f Þ 1=2 ¼ 1 2 cos ðcos þ 1Þ ð 7Þ
This cone angle model is useful in grasping changes in the conformational dynamics of the folding/unfolding of protein. As shown schematically in Fig. 7 , the segmental motion of Trp9 was more suppressed in the compact domain including the -helix, and on the other hand that of Trp54 was given larger freedom in the loosened loop structure in the conformational transition to the intermediate state. Such heterogeneous packing of BGTI is very interesting considering the protein folding process and mechanism. It is generally accepted that the MG state is stabilized by specific interaction between the -helices. Furthermore, Itzhaki et al. have suggested that the nucleation site of chymotrypsin inhibitor 2, the three-dimensional structure of which is very similar to BGTI, is formed in the -helix domain. 13) It is not yet confirmed that the MG state holds a specific nucleation site as proposed in the nucleation condensation model of protein folding. But the heterogeneously compact conformation of BGTI observed here may closely correlate with the nucleation for the protein structure condensation. 
